Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 9,999 Oruka Therapeutics, Inc. shares (Form 4)

Traded Oct 12, 2026 · Filed Oct 13, 2026

On Oct 12, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 9,999 Oruka Therapeutics, Inc. shares at an average US$80.60 for US$806K under a trading plan, leaving 14,219 shares. Filed Oct 13, 2026 (Form 4).

Sold
9,999 shares
Price
US$80.60 average (US$80.03 to US$82.84)
Value
US$806K
Holding after
14,219 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Senior Vice President, Finance

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 12, 2026Common StockOption exercise8,541US$12.5022,760Direct
Oct 12, 2026Common StockOption exercise1,458US$34.3924,218Direct
Oct 12, 2026Common StockSale5,741US$80.0318,477Direct
Oct 12, 2026Common StockSale2,100US$80.7616,377Direct
Oct 12, 2026Common StockSale1,958US$81.8614,419Direct
Oct 12, 2026Common StockSale200US$82.8414,219Direct

Source

View original at SEC

Related